Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Evaluation of human epidermal growth factor receptor 2 in breast cancer with a novel specific aptamer

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1.

References

  1. Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD . The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012; 36: 237–248.

    Article  PubMed  Google Scholar 

  2. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011; 22: 1736–1747.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cooke T, Reeves J, Lanigan A, Stanton P . HER2 as a prognostic and predictive marker for breast cancer. Ann Oncol 2001; 12: S23–S28.

    Article  PubMed  Google Scholar 

  4. Holbro T, Civenni G, Hynes NE . The ErbB receptors and their role in cancer progression. Exp Cell Res 2003; 284: 99–110.

    Article  CAS  PubMed  Google Scholar 

  5. Hoang MP, Sahin AA, Ordonez NG, Sneige N . HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. Am J Clin Pathol 2000; 113: 852–859.

    Article  CAS  PubMed  Google Scholar 

  6. Lebeau A, Deimling D, Kaltz C, Sendelhofert A, Iff A, Luthardt B et al. Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization. J Clin Oncol 2001; 19: 354–363.

    Article  CAS  PubMed  Google Scholar 

  7. Tuerk C, Gold L . Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505–510.

    Article  CAS  Google Scholar 

  8. Konry T, Hayman RB, Walt DR . Microspherebased rolling circle amplification microarray for the detection of DNA and proteins in a single assay. Anal Chem 2009; 81: 5777–5782.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Liu Z, Duan JH, Song YM, Ma J, Wang FD, Lu X et al. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. J Transl Med 2012; 10: 148.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Baner J, Nilsson M, Mendel-Hartvig M, Landegren U . Signal amplification of padlock probes by rolling circle replication. Nucleic Acids Res 1998; 26: 5073–5078.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chu, M., Kang, Jr., Wang, W. et al. Evaluation of human epidermal growth factor receptor 2 in breast cancer with a novel specific aptamer. Cell Mol Immunol 14, 398–400 (2017). https://doi.org/10.1038/cmi.2015.31

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cmi.2015.31

This article is cited by

Search

Quick links